Sandostatin LAR 10 mg/vial (Injection)
10 mg vial: ৳ 14,490.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Octreotide acetate |
| Company | Novartis bangladesh ltd |
| Also available as |
Indications
- Acromegaly
- Carcinoid Tumors
- Vasoactive Intestinal Peptide Tumors
- Symptomatic treatment
- Reduction of growth hormone levels
- Reduction of IGF-I levels
- Suppress diarrhea and flushing episodes
Pharmacology
- Synthetic analogue of somatostatin
- Suppression of growth hormone secretion
- Suppression of LH response
- Reduction of gastrin secretion
- Reduction of insulin secretion
- Reduction of glucagon secretion
Dosage & Administration
- Intramuscular administration
- Intravenous administration
- Subcutaneous administration
- Prophylaxis of complications following pancreatic surgery
- Treatment for variceal haemorrhage in cirrhosis patients
Interaction
- Dosage adjustment with concurrent therapy may be necessary
- Interactions with calcium channel blockers
- Interactions with oral hypoglycaemics
- Interactions with beta-blockers
- Interactions with diuretics
Contraindications
- Hypersensitivity
Side Effects
- Local pain at site of injection
- Stinging at site of injection
- Tingling at site of injection
- Anorexia
- Nausea
- Vomiting
- Abdominal pain
- Bloating
- Flatulence
- Loose stools
- Steatorrhoea
- Hypoglycaemia
- Hyperglycaemia
- Hypothyroidism
- Cardiac conduction abnormalities
- Pancreatitis
Pregnancy & Lactation
- Category B for pregnancy
- No evidence of risk in later trimesters
Precautions & Warnings
- Renal disease
- Risk of gall bladder disease
- Diabetes mellitus
- Hypothyroidism
- Monitor levels of vitamin B12 during long term therapy
Use in Special Populations
- Dosage reduction in severe renal impairment requiring dialysis
Therapeutic Class
- Growth hormone antagonist
Storage Conditions
- Store at 2-8° C
- Stable at room temperature for up to 14 days